CONMED Corporation (CNMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in CONMED Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

CONMED Corporation (CNMD) has returned -12.91% so far this year and -41.01% over the past 12 months. Over the last ten years, CNMD has returned -0.87% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Mar 26, 1990, CNMD's average daily return is +0.08%, while the average monthly return is +1.51%. At this rate, your investment would double in approximately 3.9 years.

Historically, 56% of months were positive and 44% were negative. The best month was Nov 1990 with a return of +60.0%, while the worst month was Jul 2000 at -48.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.

On a daily basis, CNMD closed higher 48% of trading days. The best single day was Mar 24, 2020 with a return of +21.8%, while the worst single day was Oct 9, 1992 at -47.9%.

CONMED Corporation has an annualized alpha of 13.37%, beta of 0.86, and R² of 0.11 versus S&P 500 Index. Calculated based on daily prices since March 27, 1990.

• This stock captured 111.75% of S&P 500 Index gains and 102.15% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.11 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CNMD ranks 6 for risk / return — in the bottom 6% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for CONMED Corporation (CNMD) and compare them to a chosen benchmark (S&P 500 Index).

CONMED Corporation provided a 1.13% dividend yield over the last twelve months, with an annual payout of $0.40 per share.

The table displays the monthly dividend distributions for CONMED Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the CONMED Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CONMED Corporation was 77.85%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current CONMED Corporation drawdown is 76.61%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of CONMED Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how CONMED Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.